These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 23386590)

  • 1. Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma.
    Xie J; Zhang Y; Zhang Q; Han Y; Yin J; Pu R; Shen Q; Lu W; Du Y; Zhao J; Han X; Zhang H; Cao G
    Hepatology; 2013 Jun; 57(6):2369-77. PubMed ID: 23386590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
    Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma.
    Zhang Q; Ji XW; Hou XM; Lu FM; Du Y; Yin JH; Sun XY; Deng Y; Zhao J; Han X; Yang GS; Zhang HW; Chen XM; Shen HB; Wang HY; Cao GW
    Ann Oncol; 2014 Dec; 25(12):2413-2419. PubMed ID: 25223483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Associations between gene polymorphisms of signal transducer and activator of transcription 3 and the susceptibility to hepatitis B virus related liver cirrhosis].
    Yan XH; Wu JL; Yu R; Ma XH; Li QF; Xie RF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Feb; 56(2):185-191. PubMed ID: 35184448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y; Pu R; Han X; Zhao J; Zhang Y; Zhang Q; Yin J; Xie J; Shen Q; Deng Y; Ding Y; Li W; Li J; Zhang H; Cao G
    PLoS One; 2013; 8(3):e58564. PubMed ID: 23516510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.
    Liu S; Zhang H; Gu C; Yin J; He Y; Xie J; Cao G
    J Natl Cancer Inst; 2009 Aug; 101(15):1066-82. PubMed ID: 19574418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of polymorphism rs1053005 in STAT3 with chronic hepatitis B virus infection in Han Chinese population.
    Li M; Li F; Li N; Sang J; Fan X; Deng H; Zhang X; Han Q; Lv Y; Liu Z
    BMC Med Genet; 2018 Apr; 19(1):52. PubMed ID: 29609539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes.
    Song XM; Li QL; Guo F; Peng H; Guo JJ
    Ann Hepatol; 2018 Oct; 17(6):940-947. PubMed ID: 30600290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population.
    Zhao Y; Chen K; Yang H; Zhang F; Ding L; Liu Y; Zhang L; Zhang Y; Wang H; Deng Y
    Virol J; 2023 Nov; 20(1):283. PubMed ID: 38037048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations.
    Zhang Q; Yin J; Zhang Y; Deng Y; Ji X; Du Y; Pu R; Han Y; Zhao J; Han X; Zhang H; Cao G
    J Virol; 2013 Nov; 87(22):12176-86. PubMed ID: 24006435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single Nucleotide Polymorphisms in STAT3 and STAT4 and Risk of Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B.
    Chanthra N; Payungporn S; Chuaypen N; Piratanantatavorn K; Pinjaroen N; Poovorawan Y; Tangkijvanich P
    Asian Pac J Cancer Prev; 2015; 16(18):8405-10. PubMed ID: 26745093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Single Nucleotide Polymorphism rs1053004 in Signal Transducer and Activator of Transcription 3 (STAT3) with Susceptibility to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B.
    Chanthra N; Payungporn S; Chuaypen N; Pinjaroen N; Poovorawan Y; Tangkijvanich P
    Asian Pac J Cancer Prev; 2015; 16(12):5069-73. PubMed ID: 26163643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A matched case-control study of hepatitis B virus mutations in the preS and core promoter regions associated independently with hepatocellular carcinoma.
    Liu S; Xie J; Yin J; Zhang H; Zhang Q; Pu R; Li C; Ni W; Wang H; Cao G
    J Med Virol; 2011 Jan; 83(1):45-53. PubMed ID: 21108338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of the interactions of STAT4 rs7574865 with HBV mutations on the risk of hepatocellular carcinoma.
    Yang C; Chen H; Zhou B; Yin J; Cao G; Hou J; Jiang D
    Mol Carcinog; 2022 Oct; 61(10):933-940. PubMed ID: 35880842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of STAT3 rs1053004 single nucleotide polymorphism in patients with chronic hepatitis B and hepatocellular carcinoma.
    Fatemipour M; Arabzadeh SAM; Molaei H; Geramizadeh B; Dabiri S; Fatemipour B; Vahedi SM; Malekpour Afshar R
    Cell Mol Biol (Noisy-le-grand); 2017 Dec; 63(12):45-50. PubMed ID: 29307341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinations of eight key mutations in the X/preC region and genomic activity of hepatitis B virus are associated with hepatocellular carcinoma.
    Park YM; Jang JW; Yoo SH; Kim SH; Oh IM; Park SJ; Jang YS; Lee SJ
    J Viral Hepat; 2014 Mar; 21(3):171-7. PubMed ID: 24344773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
    Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
    Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.
    Yang HI; Yeh SH; Chen PJ; Iloeje UH; Jen CL; Su J; Wang LY; Lu SN; You SL; Chen DS; Liaw YF; Chen CJ;
    J Natl Cancer Inst; 2008 Aug; 100(16):1134-43. PubMed ID: 18695135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIM3 gene polymorphisms in patients with chronic hepatitis B virus infection: impact on disease susceptibility and hepatocellular carcinoma traits.
    Li Z; Liu Z; Zhang G; Han Q; Li N; Zhu Q; Lv Y; Chen J; Xing F; Wang Y; Li F
    Tissue Antigens; 2012 Aug; 80(2):151-7. PubMed ID: 22587604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.